Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · IEX Real-Time Price · USD
1.410
+0.060 (4.44%)
At close: Jul 19, 2024, 4:00 PM
1.580
+0.170 (12.06%)
Pre-market: Jul 22, 2024, 7:22 AM EDT
Company Description
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.
Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
The company develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders.
It has an agreement with NoiseFigure Research, Inc. to develop next generation of its proprietary microchip.
Autonomix Medical, Inc. was incorporated in 2014 and is based in The Woodlands, Texas.
Autonomix Medical, Inc.
| Country | United States |
| Founded | 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Bradley Hauser |
Contact Details
Address: 21 Waterway Avenue, Suite 300 The Woodlands, Texas 77380 United States | |
| Phone | 832-277-7816 |
| Website | autonomix.com |
Stock Details
| Ticker Symbol | AMIX |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001617867 |
| ISIN Number | US05330T1060 |
| Employer ID | 47-1607810 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Lori H. Bisson | Chief Executive Officer and Director |
| Walter V. Klemp | Executive Chairman |
| Dr. Robert Schwartz M.D. | Co-Founder and Chief Medical Officer |
| Landy Toth | Co-Founder and Chief Technology Officer |
| Trent N. Smith CPA | Chief Financial Officer |
| Jennifer Cook | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 15, 2024 | 8-K | Current Report |
| Jun 21, 2024 | 8-K | Current Report |
| Jun 18, 2024 | 8-K | Current Report |
| Jun 17, 2024 | 8-K | Current Report |
| May 31, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 31, 2024 | 10-K | Annual Report |
| May 31, 2024 | 8-K | Current Report |
| Mar 4, 2024 | 8-K | Current Report |
| Feb 26, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Feb 15, 2024 | SC 13D | General statement of acquisition of beneficial ownership |